HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Features of a subset of children with complex partial epilepsy requiring combination therapy for effective seizure control.

Abstract
To identify children with complex partial seizures with increased risk for suboptimal seizure control with 1 medication, a computerized database containing all patients seen in the context of a single pediatric neurology practice was reviewed for patients with complex partial seizures. Participants included in analysis were then divided into groups; a group in whom seizure control was attained with a single medication (group 1) and a group for whom 2 or more medications were required for seizure control (group 2). Status epilepticus, developmental disabilities, and the presence of coexisting other seizures/types were also significantly different, with a higher predominance in group 2 children. Patients with status epilepticus, coexistent seizure types, and developmental disabilities should be identified and more carefully followed, with a lower threshold for starting these children on a combination of antiepileptic drugs adhered to.
AuthorsMatthew E Sloan, Elisabeth Simard-Tremblay, Michael I Shevell
JournalJournal of child neurology (J Child Neurol) Vol. 25 Issue 1 Pg. 43-7 (Jan 2010) ISSN: 1708-8283 [Electronic] United States
PMID19494358 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
Topics
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Child
  • Databases as Topic
  • Developmental Disabilities (complications)
  • Drug Therapy, Combination
  • Epilepsy, Complex Partial (complications, drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Retrospective Studies
  • Seizures (complications, drug therapy)
  • Status Epilepticus (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: